Skip to main navigation Skip to search Skip to main content

Cerebrospinal Fluid Levels of Angiotensin-Converting Enzyme Are Associated with Amyloid-β42 Burden in Alzheimer's Disease

  • Natalia P. Rocha
  • , Andre Toledo
  • , Laiane T.S. Corgosinho
  • , Leonardo C. de Souza
  • , Henrique C. Guimarães
  • , Elisa P.F. Resende
  • , Nayara F.T. Braz
  • , Karina B. Gomes
  • , Ana C. Simoes E Silva
  • , Paulo Caramelli
  • , Antonio L. Teixeira

Research output: Contribution to journalArticlepeer-review

Abstract

This study was designed to determine whether the levels of renin-angiotensin system (RAS) components are associated with Alzheimer's disease (AD) pathology. Cerebrospinal fluid levels of Angiotensin (Ang) II, Ang-(1-7), angiotensin-converting enzyme (ACE), ACE2, Amyloid-β (Aβ)40, Aβ42, total tau (hTau), and phospho-tau (pTau) were measured in 18 patients with AD and 10 controls. Patients with AD presented decreased levels of ACE when compared with controls. We found a significant positive correlation between ACE and Aβ42 levels among patients. Our results strengthen the hypothesis that ACE is associated with Aβ pathology in AD.

Original languageEnglish (US)
Pages (from-to)1085-1090
Number of pages6
JournalJournal of Alzheimer's Disease
Volume64
Issue number4
DOIs
StatePublished - 2018
Externally publishedYes

Keywords

  • Alzheimer’s disease
  • amyloid-beta
  • angiotensin-converting enzyme
  • biomarkers
  • renin-angiotensin system

ASJC Scopus subject areas

  • General Neuroscience
  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Cerebrospinal Fluid Levels of Angiotensin-Converting Enzyme Are Associated with Amyloid-β42 Burden in Alzheimer's Disease'. Together they form a unique fingerprint.

Cite this